PPH

VanEck Vectors Pharmaceutical ETF [PPH] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PPH Stock Summary

Top 10 Correlated ETFs

PPH

Top 10 Correlated Stocks

PPH

In the News

PPH Financial details

Company Rating
-
Market Cap
987.04M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.43
Dividend %
2%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
2.1%
SMA50
10.1%
SMA100
18.27%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
74.05-91.16
52W High
+14.62%
52W Low
+40.95%
RSI
68.46
Rel Volume
1.02
Avg Volume
125.56K
Volume
127.61K
Perf Week
1.62%
Perf Month
6.21%
Perf Quarter
18.79%
Perf Half Y
18.5%
-
-
-
-
Beta
0.6
-
-
Volatility
1.14%, 1.72%
Prev Close
0.65%
Price
104.3
Change
0.53%

PPH Financial Performance

PPH Dividend History

PPH Frequently Asked Questions

What is VanEck Vectors Pharmaceutical ETF stock symbol ?

VanEck Vectors Pharmaceutical ETF is a US stock and trading under the symbol PPH

What is VanEck Vectors Pharmaceutical ETF stock quote today ?

VanEck Vectors Pharmaceutical ETF stock price is $104.3 today.

Is VanEck Vectors Pharmaceutical ETF stock public?

Yes, VanEck Vectors Pharmaceutical ETF is a publicly traded company.

Something similar

Top by Market Cap
META
MSF.DE
TSLA
TL0.DE
AMZN
Top Correlated ETFs
XLV
FHLC
RXL
CURE
IXJ
Top Correlated Stocks
H
7512.T
REGN
MAR
HLT
Similar Market Cap
PRAJ.DE
0O33.L
SVC
MMDEX
SYX

Company Profile

Financial Services Asset Management
  • Volume Average 125.56K
  • Market Capitalization 987.04M
  • Headquarters US
  • IPO Date 2000-02-01

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.